Lower riskMedical device recall · FDA · Published November 12, 2020
Medtronic Intellis Spinal Cord Stimulator Software Issue: Cannot Program Device
Medtronic recalls Intellis Spinal Cord Stimulator model A710 software version 1.3.80 due to inability to program the implantable neurostimulation device. Affected users should contact Medtronic for assistance.
“Medtronic Intellis Spinal Cord Stimulator Software Issue: Cannot Program Device.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63926-medtronic-intellis-spinal-cord-stimulator-software-issue-cannot-program-device. Based on FDA recall #Z-0860-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0860-2021%22&limit=1).
The FDA announced on November 12, 2020, that Medtronic Neuromodulation is recalling the Intellis Spinal Cord Stimulator Clinical Programmer application version 1.3.80 due to a software issue preventing device programming. The agency issued recall number Z-0860-2021 for the Class II voluntary recall.
How to tell if you have it
Brand: Medtronic
Product: Intellis Spinal Cord Stimulator Clinical Programmer application version 1.3.80
Model Number: A710
The hazard
According to the FDA, the A710 Intillis Clinician Application contains a software issue that can result in the inability to program the Intillis implantable neurostimulation device. The recall affects 7,960 downloads distributed worldwide, including in the United States, Canada, Latin America, Asia Pacific, Japan, China, and European regions.
Context
GovInfoNow's records show Medtronic Neuromodulation has 45 other recalls on record since August 9, 2017. Other recent recalls include the Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation (May 13, 2026), the SynchroMed Flex Infusion Software Issue (April 8, 2026), and the Vanta CP App Software Recall (December 3, 2025).
How to tell if you have this one
Check if your device has the model number A710 and software version 1.3.80. This is used by clinicians for programming the spinal cord stimulator in pain therapy.
Brand
Medtronic
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Contact Medtronic
Reach out to Medtronic for assistance with the software issue and possible updates.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Worldwide distribution - US Nationwide distribution and the countries of Canada, Latin America, Asia Pacific, Japan, China, and European regions.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 2 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0860-2021 (November 12, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0860-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.